Educational content from recorded physician discussions — not medical advice. Always talk to your child's care team about your child's situation.
Content of this collection
Tools
1 item
Neuroblastoma PDQ
Read →
National Institute of Health and National Cancer Institute Neuroblastoma Treatment (PDQ®) -Health Professional Version
article · Sep 2025
High-Yield Summaries
2 items

Neuroblastoma
Listen →
Drs Erika Newman, Dan von Allmen and Tony Sandler join Dr. Todd Ponsky in a discussion covering the latest in neuroblastoma. Contributing editor: Rachel (Rae) Hanke, MD
Case 1: Mother who presents with 26 week fetus
with a pr
podcast56:19 · Dec 2020
Topics in 10: Neuroblastoma
Listen →
Drs Daniel von Allmen, Todd Ponsky and Rae Hanke come together to provide you the essentials on the diagnosis and management of Neuroblastoma. Intro and outro tracks are adapted from "I dunno" by grapes, featuring J Lang, Morusque. Artist U
podcast10:25 · Dec 2020
In-depth Review
1 item
Neuroblastoma
Watch →
Dr. Daniel von Allmen, surgeon-in-chief at Cincinnati Children’s, joins Dr. Rae Hanke to review the essentials of neuroblastoma in this videocast.
video · May 2020
Work-up and Treatment
0 items
Test Your Knowledge
1 item
Did you Know: Storycasts
Watch →
Did you know we have all new interactive cases that we like to call "StoryCasts". It's like a choose your own adventure game but right here on your phone. Watch this video to learn how to use this new feature!
video · May 2021
Summaries and takeaways+ Show
Summary of this collection+ Show
Key points, with the moment each was said+ Show
Featured picks for families are being prepared — the summaries above are written for you.
Takeaways+ Show
For patients & families
Neuroblastoma is the most common solid tumor outside the brain in children, usually appearing in babies and toddlers. Many cases are discovered before birth on ultrasound or found as a belly mass in young children. When the disease has spread, children may have bone pain or nerve problems from pressure on the spinal cord. Doctors use several tests to understand each child's tumor. They check urine or blood for special chemicals the tumor makes, and use scans like CT, MRI, and a nuclear medicine test called MIBG to see where the tumor is and whether it has spread. About one in ten neuroblastomas don't show up on the MIBG scan. A small tissue sample tells doctors important information about the tumor's biology — especially something called NMIC status — which helps determine how aggressive treatment needs to be. Treatment depends on the child's age and the tumor's characteristics. Some babies with small, localized tumors can simply be watched carefully, as many of these tumors shrink on their own. Others need chemotherapy, surgery, or both. Children with high-risk disease receive intensive treatment including strong chemotherapy, surgery to remove as much tumor as safely possible, radiation, and newer immune therapies.
Neuroblastoma is the most common solid tumor outside the brain in children, usually appearing in babies and toddlers. Many cases are discovered before birth on ultrasound or found as a belly mass in young children. When the disease has spread, children may have bone pain or nerve problems from pressure on the spinal cord. Doctors use several tests to understand each child's tumor. They check urine or blood for special chemicals the tumor makes, and use scans like CT, MRI, and a nuclear medicine test called MIBG to see where the tumor is and whether it has spread. About one in ten neuroblastomas don't show up on the MIBG scan. A small tissue sample tells doctors important information about the tumor's biology — especially something called NMIC status — which helps determine how aggressive treatment needs to be. Treatment depends on the child's age and the tumor's characteristics. Some babies with small, localized tumors can simply be watched carefully, as many of these tumors shrink on their own. Others need chemotherapy, surgery, or both. Children with high-risk disease receive intensive treatment including strong chemotherapy, surgery to remove as much tumor as safely possible, radiation, and newer immune therapies.
The doctors in this collection+ Show
All expert statements+ Show
Every expert statement below comes from the recorded discussions, with its speaker and moment.
Neuroblastoma
Adrenal hemorrhage is the most common differential diagnosis for prenatal suprarenal mass, more common with history of fetal stress
clinicalDaniel von Allmen2:11 ↗
Other differential diagnoses for suprarenal mass include neuroblastoma, pulmonary sequestration below the diaphragm, and misdiagnosed renal anomaly
clinicalDaniel von Allmen2:11 ↗
Familial neuroblastoma occurs in about 1% of patients
epidemiologicalTony Sandler4:39 ↗
For prenatal suprarenal mass, first postnatal study should be ultrasound of the abdomen
guidelineTodd Ponsky5:07 ↗
CT scan or MRI not needed for 3 cm lesion unless urine catecholamines are elevated
guidelineTony Sandler5:34 ↗
MIBG scan is the next step if catecholamines are elevated
guidelineDaniel von Allmen6:02 ↗
Radiologists are quite good at identifying adrenal hemorrhage on ultrasound
opinionDaniel von Allmen6:02 ↗
In perinatal phase, most common metastatic sites are liver, bone, skin, and lymph nodes
clinicalDaniel von Allmen8:14 ↗
Nocktern study data supports observation of prenatal neuroblastoma with careful ultrasound surveillance
guidelineDaniel von Allmen8:44 ↗
Of 84 observed patients in Nocktern study, 16 (approximately 20%) underwent resection for growth or family preference
epidemiologicalTony Sandler10:39 ↗
Nocktern study showed approximately 98% event-free survival and 100% overall survival in observed prenatal neuroblastoma
epidemiologicalErika Newman11:07 ↗
First-year surveillance protocol: ultrasound and catecholamines at birth, 3 weeks, 6 weeks, 12 weeks, then spaced out to one year
guidelineErika Newman11:37 ↗
After one year, surveillance becomes every six months, then yearly
guidelineErika Newman11:37 ↗
Case report: child with observed prenatal adrenal mass that resolved presented at age 3 with widely metastatic high-risk neuroblastoma
clinicalDaniel von Allmen12:27 ↗
5 centimeters is used as size cutoff for surgical intervention in observed prenatal masses
guidelineTony Sandler14:36 ↗
Volume increase of more than 50% is criterion for considering surgery
guidelineTodd Ponsky15:08 ↗
50% increase in VMA or HVA prompts consideration of surgery
guidelineTodd Ponsky15:08 ↗
Laparoscopic approach is reasonable for masses less than 6 centimeters
guidelineErika Newman16:07 ↗
Lymph node status in neuroblastoma is not as important for therapy changes as in Wilms tumor
clinicalDaniel von Allmen16:36 ↗
Biology of neuroblastoma is more important than lymph node status for treatment decisions
clinicalErika Newman17:00 ↗
Stage MS (formerly 4S) with skin lesions and liver mets still tends to have good biology
clinicalErika Newman17:30 ↗
Primary concern in stage MS with liver involvement is mass effect causing respiratory compromise
clinicalDaniel von Allmen17:58 ↗
Stage MS without distress can be treated with aggressive observation
guidelineErika Newman17:58 ↗
Once respiratory compromise begins, treatment options include chemotherapy, radiation, or emergent decompressive laparotomy
guidelineErika Newman17:58 ↗
Classic findings of stage MS (high catecholamines, blue blebs on skin, liver metastasis, adrenal mass) may not require biopsy
opinionDaniel von Allmen19:06 ↗
Liver biopsy in newborns is difficult because bleeding is hard to control
clinicalErika Newman19:52 ↗
If NMYC is amplified in stage MS, staging changes from MS to M
clinicalTodd Ponsky20:40 ↗
VIP secretion can cause severe diarrhea in neuroblastoma
clinicalErika Newman21:05 ↗
Initial workup for abdominal mass includes ultrasound to determine solid vs cystic, then CT with PO and IV contrast if solid
guidelineErika Newman21:05 ↗
Ultrasound is important for Wilms tumor to assess venous extension
clinicalTony Sandler22:56 ↗
What's new+ Show
